中国急性心力衰竭急诊临床实践指南

doi:10.3969/j.issn.1002-1949.2017.12.001

摘要
图/表
参考文献(70)
相关文章 (15)

全文: PDF (1616 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要心力衰竭(heart failure，简称心衰)是由于心脏结构或功能异常导致心室充盈或射血能力受损的一组临床综合征，其病理生理学特征为肺淤血和（或）体循环淤血以及组织器官低灌注，主要临床表现为呼吸困难、乏力(活动耐量受限)以及液体潴留(外周水肿)。 急性心力衰竭（acute heart failure，AHF）是指继发于心脏功能异常而迅速发生或恶化的症状和体征，并伴有血浆利钠肽水平的升高，既可以是急性起病，也可以表现为慢性心衰急性失代偿（acute decompensated heart failure，ADHF），其中后者更为多见，占70%～80%。临床上最为常见的AHF是急性左心衰，急性右心衰虽较少见，但近年有增加的趋势。基于右心从胚胎起源、结构及功能皆不同于左心，本指南主要述及急性左心衰的相关内容。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	中国医师协会急诊医师分会
	中国心胸血管麻醉学会急救与复苏分会

收稿日期: 2017-10-29

通讯作者: 张新超（北京医院急诊科，国家老年医学中心，E-mail: xinchaoz@163.com）；马青变(北京大学第三医院急诊科，E-mail: maqingbian@bjmu.edu.cn) ；于学忠（北京协和医院急诊科，E-mail: yxz@medmail.com.cn）

作者简介: 专家组成员：陈峰(福建省立医院);陈凤英(内蒙古医学院附属医院);陈晓辉(广州医科大学);陈志(北京市急救中心);邓颖(哈尔滨医科大学第二附属医院);黄亮(江西医科大学第一附属医院);梁显泉(贵阳市第二医院);蔺佩鸿(福建医科大学第一附属医院);刘明华(陆军军医大学西南医院);卢中秋(温州医科大学第一附属医院);吕瑞娟(山东大学齐鲁医院);马青变(北京大学第三医院);米玉红(北京安贞医院);钱传云(云南医科大学第一附属医院);商德亚(山东省立医院);田英平(河北医科大学第二附属医院);杨立山(宁夏医科大学总医院);杨艳敏(北京阜外医院，国家心血管病中心);魏捷(武汉大学人民医院);温伟(北京医院);许铁(徐州医学院附属医院);于学忠(北京协和医院);张新超(北京医院);赵敏(中国医科大学附属盛京医院);赵晓东(解放军总医院第一附属医院);尹文(空军军医大学西京医院);周荣斌(陆军总医院);朱华栋(北京协和医院);朱继红(北京大学人民医院)

引用本文:

中国医师协会急诊医师分会，中国心胸血管麻醉学会急救与复苏分会. 中国急性心力衰竭急诊临床实践指南[J]. 中国急救医学, 2017, 37(12): 1063-1074.

链接本文:

http://www.cnemergency.org.cn/CN/10.3969/j.issn.1002-1949.2017.12.001 或 http://www.cnemergency.org.cn/CN/Y2017/V37/I12/1063

［1］Moe GW, Howlett J, Januzzi JL, et al. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study［J］. Circulation, 2007, 115(24):3103-3110. ［2］Maisel A, Mueller C, Nowak R, et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea［J］. J Am Coll Cardiol, 2010, 55(19):2062-2076. ［3］Roberts E, Ludman AJ, Dworzynski K, et al. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting［J］. BMJ, 2015, 350: h910. ［4］Kelder JC, Cramer MJ, Verweij WM, et al. Clinical utility of three B-type natriuretic peptide assays for the initial diagnostic assessment of new slow-onset heart failure［J］. J Card Fail, 2011, 17(9):729-734. ［5］Kelder JC, Cowie MR, McDonagh TA, et al. Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis［J］. Heart, 2011, 97(12):959-963. ［6］Richards AM, Nicholls MG, Espiner EA, et al. B-type natriureic peptides and ejection fraction for prognosis after myocardial infarction［J］. Circulation, 2003, 107(22):2786-2792.  ［7］Kolin J, Pehlivanli S, Schwaiblmair M, et al. Role of brain natriureic peptide in risk stratification of patient with congestive heart failure［J］. J Am Coll Cardiol, 2001, 38(7):1934-1941. ［8］Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism［J］. Eur Heart J, 2014, 35(45):3033-3069. ［9］Felker GM, Mentz RJ, Teerlink JR, et al. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study［J］. Eur J Heart Fail, 2015, 17(12):1262-1270. ［10］Miller WL, Hartman KA, Burritt MF, et al. Serial biomarker measurements in ambulatory patients with chronic heart failure［J］. Circulation, 2007, 116(3): 249-257. ［11］Xue Y. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure［J］. Eur J Heart Fail, 2011, 13(1): 37-42. ［12］Januzzi JL Jr, Peacock WF, Maisel AS, et al. Measurement of the interleukin familymember ST2 in patients with acute dyspnea: results from the PRIDE (Pro-brain natriuretic peptide investigation of dyspnea in the emergency department) study［J］. J Am Coll Cardiol, 2007,50(7): 607-613. ［13］Aldous SJ. Richards AM. Troughton R. et al. ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency departmentwithchest pain［J］. J Card Fail, 2012, 18(4):304-310. ［14］胡振, 张新超. 血清可溶性ST2评价老年急性心衰患者病情与预后的研究［J］. 中华急诊医学杂志，2016, 25(8):746-749. ［15］Maisel A. Increased 90-day mortality in patients with acute heart failure with elevated copeptin［J］. Circ Heart Fail, 2011, 4(5):613-620. ［16］Alehagen U, Dahlstrom U, Rehfeld JF, et al. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure［J］. JAMA, 2011, 305(20): 2088-2095. ［17］Wang CS, FitzGerald JM, Schulzer M, et al. Does this dyspneic patient in the emergency department have congestive heart failure［J］. JAMA, 2005, 294(15):1944-1956. ［18］Chakko S, Woska D, Martinez H, et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care［J］. Am J Med, 1991, 90(3):353-359. ［19］Temporelli PL, Scapellato F, Eleuteri E, et al. Doppler echocardiography in advancd systolic heart failure: a noninvasive alternative to Swan-Ganz catheter［J］. Circ Heart Fail, 2010, 3(3):387. ［20］急诊超声标准操作规范专家组. 急诊超声标准操作规范［J］. 中国急救医学, 2013, 33(7): 577-591. ［21］Levy B. Lactate and shock state: the metabolic view［J］. Curr Opin Crit Care, 2006, 12(4):315-321. ［22］Jansen TC, van Bommel J, Schoonderbeek FJ, et al. LACTATE study group: Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial［J］. Am J Respir Crit Care Med, 2010, 182(6):752-761. ［23］Casserly B, Phillips GS, Schorr C, et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database［J］. Crit Care Med, 2015, 43(3):567-573. ［24］Manzano-Fernandez S, Januzzi JL, Boronat-Garcia M, et al. β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure［J］.J Am Coll Cardiol, 2011, 57(7): 849-858. ［25］de Geus HR, Bakker J, Lesaffre EM, et al. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients［J］. Am J Respir Crit Care Med, 2011,183(7):907-914. ［26］Haase M, Devarajan P, Haase-Fielitz A, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies［J］. J Am Coll Cardiol, 2011, 57(17):1752-1761. ［27］Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure［J］. J Am Coll Cardiol, 2003, 41(10):1797-1804. ［28］Stevenson LW. Design of therapy for advanced heart failure［J］. Eur J Heart Fail, 2005, 7(3):323-331. ［29］Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients［J］. Am J Cardiol, 1967, 20(4):457-464. ［30］Wang GG, Wang SG, Qin J, et al. Characteristics, Management, and Outcomes of Acute Heart Failure in Emergency Department: A Multicenter Registry Study with 1-year Follow-up in a Chinese Cohort in Beijing［J］. Chin Med J, 2017, 130(16): 1894-1901. ［31］Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guides on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(4):384-416. ［32］Eskesen TG, Wetterslev M, Perner A. Systematic review including re-analyses of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness［J］. Intensive Care Med, 2016, 42(3): 324-332. ［33］L′Her E, Duquesne F, Girou E, et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients［J］. Intensive Care Med, 2004, 30(5):882-888. ［34］Bellone A, Monari A, Cortellaro F, et al. myocardial infarction rate in acute pulmonary edema: noninvasive pressure support ventilation versus continuous positive airway pressure［J］. Crit Care Med, 2004, 32(9):1860-1865. ［35］Masip J. Non-invasive ventilation［J］. Heart Fail Review, 2007, 12(2):119-124. ［36］Ritchie JE,Williams AB,Gerard C，et al.Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures［J］.Anaesth Intensive Care, 2011, 9(6):1103-1110. ［37］Rawles JM, Kenmure AC. Controlled trial of oxygen in uncomplicated myocardial infarction［J］. Br Med J, 1976, 1(6018):1121-1123. ［38］Park JH, Balmain S, Berry C, et al. Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction［J］. Heart, 2010, 96(7):533-538. ［39］De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock［J］. N Engl J Med, 2010, 362(9):779-789. ［40］Priori SG, Blomstro¨m-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Europe Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)［J］. Eur Heart J, 2015, 36(41):2793-2867. ［41］Kirchof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS［J］. Eur J Cardiothorac Surg, 2016, 50(5):e1-e88. ［42］Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association［J］. Eur Heart J, 2013, 34(29):2281-2329. ［43］Felker GM, O′Connor CM, Braunwald E, Heart Failure Clinical Research Network Investigators. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil［J］. Circ Heart Fail, 2009, 2(1):56-62. ［44］WRITING COMMITTEE MEMBERS, Yancy CW, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines［J］. Circulation, 2013, 128(16): e240. ［45］Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure［J］. N Engl J Med, 2011, 364(9): 797. ［46］Konstam MA, Gheorghiade M, Burnett JC Jr. et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome tria［J］l. JAMA, 2007, 297:1319-1331. ［47］Cotter G, Metzkor E, Kaluski E, et al. Randomized trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary edema［J］. Lancet, 1998, 351(9100):389-393. ［48］Abraham WT, Adams KF, Fonarow GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry(ADHERE)［J］. J Am Coll Cardiol, 2005, 46(1):57-64. ［49］Publication committee for the VMAC investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial［J］. JAMA, 2002, 287(12):1531-1540. ［50］O′Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure［J］. N Eng J Med, 2011, 365(1):32-43. ［51］重组人脑利钠肽多中心研究协作组. 重组人脑利钠肽治疗心衰安全性和疗效的开放性随机对照多中心临床研究［J］. 中华心血管病杂志, 2011, 39(4):305-308. ［52］He JY, Wang J, Hua Q, et al. Safety and efficacy of urapidil and nitroglycerin in the treatment of elderly patients with acute heart failure: a randomized multicenter parallel-control study in China［J］. Int J Clin Exp Med, 2017, 10(6): 9729-9739. ［53］Felker GM, Benza RL, Chandler AB, et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study［J］. J Am Coll Cardiol, 2003, 41(6):997. ［54］Abraham WT, Adams KF, Fonarow GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)［J］. J Am Coll Cardiol, 2005, 46(1):57. ［55］Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial［J］. Lancet, 2002, 360(9328):196-202. ［56］Moiseyev VS, Poder P, Andrejevs N, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: A randomized, placebo-controlled, double-blind study (RUSSLAN)［J］. Eur Heart J, 2002, 23(18): 1422-1432. ［57］Mebazaa A, Nieminen MS, Packer M，et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial［J］. JAMA, 2007, 297(17):1883-1891. ［58］王雷, 崔亮, 魏嘉平, 等. 静脉注射左西孟旦治疗重度失代偿心衰患者的疗效分析［J］. 中华心血管病杂志, 2010, 38(6):527-530. ［59］张宇辉, 张健,卿恩明, 等. 国产左西孟旦与多巴酚丁胺治疗急性失代偿性心衰患者临床研究［J］. 中华心血管病杂志, 2012, 40(3):153-156. ［60］Peacock WF,Hollander JE,Diercks DB, et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis［J］. Emerg Med J, 2008, 25(4):205-209. ［61］Jafri SM．Hypercoagulability in heart failure［J］．Semin Thromb Hemost，1997, 23(6)：543-545． ［62］Ahnert AM, Freudenberger RS．What do we know about anticoagulation in patients with heart failure［J］. Curr Opin Caldiol, 2008, 23(3): 228-232． ［63］Beemath A, Stein PD, Skaf E, et al．Risk of venous thromboembolism in patients hospitalized with heart failure［J］. Am J Caldiol, 2006, 98(6): 793-795． ［64］Klein L, O′connell JB．Thromboembolic risk in the patient with heart failure［J］. Curr Treat Options in Cardiovasc Med, 2007, 9(4): 310-317. ［65］Metra M, Torp-Pedersen C, Cleland JG, et al. Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure Results from COMET［J］. Eur J Heart Fail, 2007, 9(9): 901. ［66］Fonarow GC, Abraham WT, Albert NM, et al. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program［J］. J Am Coll Cardiol, 2008, 52(3):190. ［67］Orso F, Baldasseroni S, Fabbri G, et al. Role of beta-blockers in patients admitted for worsening heart failure in a real world setting: data from the Italian Survey on Acute Heart Failure［J］. Eur J Heart Fail, 2009, 11(1):77. ［68］Mentz RJ, Kjeldsen K, Rossi GP, et al. Decongestion in acute heart failure［J］. Eur J Heart Fail, 2014, 16(5):471-482. ［69］Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome［J］. N Engl J Med, 2012, 367(24):2296-2304. ［70］Mebazaa A, Parissis J, Porcher R, et al. Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods［J］. Intensive Care Med, 2011, 37(2):290-301.